Originally developed to treat type 2 diabetes, these medications were found to be highly effective for weight loss, leading to their widespread off-label use and, in some cases, FDA approval for weight management
That said, oral B6 supplementation at 10-25 mg daily is a reasonable, lower-cost alternative for people who cannot access the compound formulation
Consequently, concerted efforts to decrease lipid components in these organs are the most efficacious therapeutic targets for treating IR and metabolic diseases
Compounded medications are custom-made by a pharmacy for an individual patient, usually when an FDA-approved drug isn't available or a patient has a specific need (like an allergy to an ingredient in the commercial product)
Tirzepatide is a GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist